VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024
Axim Biotechnologies, Inc (AXIM)
NASDAQ:AMEX Investor Relations:
aximbiotech.com
Company Research
Source: GlobeNewswire
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s SAN DIEGO, CA, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, today released a fireside chat interview conducted with its CEO John Huemoeller II and Tony Noto at the 2024 Benzinga Virtual Healthcare Summit. During the presentation, Mr. Huemoeller shares insights into the Company’s work with its two FDA-cleared ophthalmological diagnostic assays currently being marketed to clinicians throughout the country as well as research being conducted in its Parkinson’s diagnostic program. The presentation can be viewed here: https://aximbiotech.com/presentations/ “We’re in the diagnostic solutions segment using teardrops and have mastered a couple of tests already, Lactoferrin which is for dry eye d
Show less
Read more
Impact Snapshot
Event Time:
AXIM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXIM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXIM alerts
High impacting Axim Biotechnologies, Inc news events
Weekly update
A roundup of the hottest topics
AXIM
News
- VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024 [Yahoo! Finance]Yahoo! Finance
- AXIM Biotechnologies Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation [Yahoo! Finance]Yahoo! Finance
- AXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical ValidationGlobeNewswire
AXIM
Sec Filings
- 4/16/24 - Form 10-K
- 4/1/24 - Form NT
- 3/21/24 - Form 8-K
- AXIM's page on the SEC website